The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused
substantial global morbidity and deaths, leading governments to turn to non-pharmaceutical …

Human coronaviruses (HCoVs) have been considered to be relatively harmless respiratory
pathogens in the past. However, after the outbreak of the severe acute respiratory syndrome …

Background Antimicrobial resistance (AMR) poses a major threat to human health around
the world. Previous publications have estimated the effect of AMR on incidence, deaths …

Background Reducing the burden of death due to infection is an urgent global public health
priority. Previous studies have estimated the number of deaths associated with drug …

These clinical practice guidelines are an update of the guidelines published by the
Infectious Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza …

The most severe sequelae after rehabilitation from SARS are femoral head necrosis and
pulmonary fibrosis. We performed a 15-year follow-up on the lung and bone conditions of …

Abstract The coronavirus disease 2019 (COVID-19) pandemic continues to cause morbidity
and mortality. Since SARS coronavirus 2 (SARS-CoV-2) was identified as the cause for …

Nationwide prospective surveillance of all-age patients with acute respiratory infections was
conducted in China between 2009‒2019. Here we report the etiological and …

Background Whether the antiinflammatory and immunomodulatory effects of glucocorticoids
may decrease mortality among patients with severe community-acquired pneumonia is …

Background Understanding the burden of community-acquired pneumonia (CAP) is critical
to allocate resources for prevention, management, and research. The objectives of this study …